The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist).

Susan F.  Slovin

Consulting or Advisory Role - Bayer

Chiara  Melloni

Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Luitpold Pharmaceuticals (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); St. Jude Medical (Inst)

Samreen  Mansor-Lefebvre

Stock and Other Ownership Interests  - Ferring

Anders  Neijber

Employment - Ferring

Stock and Other Ownership Interests  - Ferring

Matthew  Roe

No Relationships to Disclose